Title Authors Source Title Publication Year Volume Issue Beginning Page Ending Page
1 Monitoring cytokine profiles during immunotherapy Siebert, Janet C.; Walker, Edwin B. IMMUNOTHERAPY 2010 2 6 799 816
2 Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories Gill, Dilbinder K.; Huang, Yunda; Levine, Gail L.; Sambor, Anna; Carter, Donald K.; Sato, Alicia; Kopycinski, Jakub; Hayes, Peter; Hahn, Bridget; Birungi, Josephine; Tarragona-Fiol, Tony; Wan, Hong; Randles, Mark; Cooper, Andrew Raxworthy; Ssemaganda, Aloysius; Clark, Lorna; Kaleebu, Pontiano; Self, Steven G.; Koup, Richard; Wood, Blake; McElrath, M. Juliana; Cox, Josephine H.; Hural, John; Gilmour, Jill PLOS ONE 2010 5 12
3 MHC-peptide tetramers for the analysis of antigen-specific T cells Sims, Stuart; Willberg, Christian; Klenerman, Paul EXPERT REVIEW OF VACCINES 2010 9 7 765 774
4 T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays Martin, Stefan F.; Esser, Philipp R.; Schmucker, Sonja; Dietz, Lisa; Naisbitt, Dean J.; Park, B. Kevin; Vocanson, Marc; Nicolas, Jean-Francois; Keller, Monika; Pichler, Werner J.; Peiser, Matthias; Luch, Andreas; Wanner, Reinhard; Maggi, Enrico; Cavani, Andrea; Rustemeyer, Thomas; Richter, Anne; Thierse, Hermann-Josef; Sallusto, Federica CELLULAR AND MOLECULAR LIFE SCIENCES 2010 67 24 4171 4184
5 Dendritic Cells Are They Clinically Relevant? Palucka, Karolina; Ueno, Hideki; Roberts, Lee; Fay, Joseph; Banchereau, Jacques CANCER JOURNAL 2010 16 4 318 324
6 Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines Sasada, Tetsuro; Komatsu, Nobukazu; Suekane, Shigetaka; Yamada, Akira; Noguchi, Masanori; Itoh, Kyogo EUROPEAN JOURNAL OF CANCER 2010 46 9 1514 1519
7 Development and application of 'phosphoflow' as a tool for immunomonitoring Wu, Sheng; Jin, Lei; Vence, Luis; Radvanyi, Laszlo G. EXPERT REVIEW OF VACCINES 2010 9 6 631 643
8 Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference Wahren, Britta; Biswas, Priscilla; Borggren, Marie; Coleman, Adam; Da Costa, Kelly; De Haes, Winni; Dieltjens, Tessa; Dispinseri, Stefania; Grupping, Katrijn; Hallengard, David; Hornig, Julia; Klein, Katja; Mainetti, Lara; Palma, Paolo; Reudelsterz, Marc; Seifried, Janna; Selhorst, Philippe; Skold, Annette; van Gils, Marit J.; Weber, Caroline; Shattock, Robin; Scarlatti, Gabriella JOURNAL OF TRANSLATIONAL MEDICINE 2010 8
9 Improved Endpoints for Cancer Immunotherapy Trials Hoos, Axel; Eggermont, Alexander M. M.; Janetzki, Sylvia; Hodi, F. Stephen; Ibrahim, Ramy; Anderson, Aparna; Humphrey, Rachel; Blumenstein, Brent; Old, Lloyd; Wolchok, Jedd JOURNAL OF THE NATIONAL CANCER INSTITUTE 2010 102 18 1388 1397
10 DNA vaccines against cancer come of age Stevenson, Freda K.; Ottensmeier, Christian H.; Rice, Jason CURRENT OPINION IN IMMUNOLOGY 2010 22 2 264 270
11 Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes Roep, Bart O.; Peakman, Mark NATURE REVIEWS IMMUNOLOGY 2010 10 2 145 152
12 Response definition criteria for ELISPOT assays revisited Moodie, Z.; Price, L.; Gouttefangeas, C.; Mander, A.; Janetzki, S.; Loewer, M.; Welters, M. J. P.; Ottensmeier, C.; van der Burg, S. H.; Britten, Cedrik M. CANCER IMMUNOLOGY IMMUNOTHERAPY 2010 59 10 1489 1501
13 A model for harmonizing flow cytometry in clinical trials Maecker, Holden T.; McCoy, J. Philip, Jr. NATURE IMMUNOLOGY 2010 11 11 975 978
14 Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity Speiser, Daniel E.; Romero, Pedro SEMINARS IN IMMUNOLOGY 2010 22 3 144 154
15 An integrative paradigm to impart quality to correlative science Kalos, Michael JOURNAL OF TRANSLATIONAL MEDICINE 2010 8
16 Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program Mander, A.; Gouttefangeas, C.; Ottensmeier, C.; Welters, M. J. P.; Low, L.; van der Burg, S. H.; Britten, C. M. CANCER IMMUNOLOGY IMMUNOTHERAPY 2010 59 4 619 627
17 Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1 Cebon, Jonathan; Knights, Ashley; Ebert, Lisa; Jackson, Heather; Chen, Weisan EXPERT REVIEW OF VACCINES 2010 9 6 617 629
18 Critical parameters in blood processing for T-cell assays: Validation on ELISpot and tetramer platforms Afonso, Georgia; Scotto, Matthieu; Renand, Amedee; Arvastsson, Jeanette; Vassilieff, Dominique; Cilio, Corrado M.; Mallone, Roberto JOURNAL OF IMMUNOLOGICAL METHODS 2010 359 1-2 28 36
19 New approaches to design HIV-1 T-cell vaccines  Perrin, Helene; Canderan, Glenda; Sekaly, Rafick-Pierre; Trautmann, Lydie CURRENT OPINION IN HIV AND AIDS 2010 5 5 368 376
20 Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop. Kettner C, Field D, Sansone SA, Taylor C, Aerts J, Binns N, Blake A, Britten CM, de Marco A, Fostel J, Gaudet P, González-Beltrán A, Hardy N, Hellemans J, Hermjakob H, Juty N, Leebens-Mack J, Maguire E, Neumann S, Orchard S, Parkinson H, Piel W, Ranganathan S, Rocca-Serra P, Santarsiero A, Shotton D, Sterk P, Untergasser A, Whetzel PL. STAND GENOMIC SCI 2010 3 3 259 266
21 Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen-A24 With Recurrent or Progressive Glioblastoma Multiforme Terasaki, Mizuhiko; Shibui, Soichiro; Narita, Yoshitaka; Fujimaki, Takamitsu; Aoki, Tomokazu; Kajiwara, Koji; Sawamura, Yutaka; Kurisu, Kaoru; Mineta, Toshihiro; Yamada, Akira; Itoh, Kyogo JOURNAL OF CLINICAL ONCOLOGY 2011 29 3 337 344
22 Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses Corse, Emily; Gottschalk, Rachel A.; Allison, James P. JOURNAL OF IMMUNOLOGY 2011 186 9 5039 5045
23 Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond Britten, C. M.; Janetzki, S.; van der Burg, S. H.; Huber, C.; Kalos, M.; Levitsky, H. I.; Maecker, H. T.; Melief, C. J. M.; O'Donnell-Tormey, J.; Odunsi, K.; Old, L. J.; Pawelec, G.; Roep, B. O.; Romero, P.; Hoos, A.; Davis, M. M. CANCER IMMUNOLOGY IMMUNOTHERAPY 2011 60 1 15 22
24 Dendritic Cell Subsets as Vectors and Targets for Improved Cancer Therapy Palucka, Karolina; Ueno, Hideki; Roberts, Lee; Fay, Joseph; Banchereau, Jacques CANCER IMMUNOLOGY AND IMMUNOTHERAPY 2011 344 173 192
25 Sources of diversity in T cell epitope discovery Chang, Cynthia Xin Lei; Dai, Lingyun; Tan, Zhen Wei; Choo, Joanna Ai Ling; Bertoletti, Antonio; Grotenbreg, Gijsbert M. FRONTIERS IN BIOSCIENCE-LANDMARK 2011 16 3014 3035
26 A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols Attig, Sebastian; Price, Leah; Janetzki, Sylvia; Kalos, Michael; Pride, Michael; McNeil, Lisa; Clay, Tim; Yuan, Jianda; Odunsi, Kunle; Hoos, Axel; Romero, Pedro; Britten, Cedrik M. JOURNAL OF TRANSLATIONAL MEDICINE 2011 9
27 Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis Davis, Mark M.; Altman, John D.; Newell, Evan W. NATURE REVIEWS IMMUNOLOGY 2011 11 8 551 558
28 Cancer immunotherapy - revisited Lesterhuis, W. Joost; Haanen, John B. A. G.; Punt, Cornelis J. A. NATURE REVIEWS DRUG DISCOVERY 2011 10 8 591 600
29 Therapeutic cancer vaccines: are we there yet? Klebanoff, Christopher A.; Acquavella, Nicolas; Yu, Zhiya; Restifo, Nicholas P. IMMUNOLOGICAL REVIEWS 2011 239 27 44
30 Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society Mallone, R.; Mannering, S. I.; Brooks-Worrell, B. M.; Durinovic-Bello, I.; Cilio, C. M.; Wong, F. S.; Schloot, N. C. CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2011 163 1 33 49
31 Biomarkers in T cell therapy clinical trials. Kalos M.  JOURNAL OF TRANSLATIONAL MEDICINE 2011 9 138
32
Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma
 Navarrete, Marcelo A.; Heining-Mikesch, Kristina; Schueler, Frank; Bertinetti-Lapatki, Cristina; Ihorst, Gabriele; Keppler-Hafkemeyer, Andrea; Doelken, Gottfried; Veelken, Hendrik
BLOOD
 2011 117 5 1483 1491
33 Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers Butterfield, Lisa H.; Palucka, A. Karolina; Britten, Cedrik M.; Dhodapkar, Madhav V.; Hakansson, Leif; Janetzki, Sylvia; Kawakami, Yutaka; Kleen, Thomas-Oliver; Lee, Peter P.; Maccalli, Cristina; Maecker, Holden T.; Maino, Vernon C.; Maio, Michele; Malyguine, Anatoli; Masucci, Giuseppe; Pawelec, Graham; Potter, Douglas M.; Rivoltini, Licia; Salazar, Lupe G.; Schendel, Dolores J.; Slingluff, Craig L., Jr.; Song, Wenru; Stroncek, David F.; Tahara, Hideaki; Thurin, Magdalena; Trinchieri, Giorgio; van Der Burg, Sjoerd H.; Whiteside, Theresa L.; Wigginton, Jon M.; Marincola, Francesco; Khleif, Samir; Fox, Bernard A.; Disis, Mary L. CLINICAL CANCER RESEARCH 2011 17 10 3064 3076
34 T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia Kalos, Michael; Levine, Bruce L.; Porter, David L.; Katz, Sharyn; Grupp, Stephan A.; Bagg, Adam; June, Carl H. SCIENCE TRANSLATIONAL MEDICINE 2011 3 95
35 Evaluation of current cancer immunotherapy: hemato-oncology. Hourigan CS, Levitsky HI. CANCER JOURNAL 2011 17 5 309 324
36 A methodological framework to enhance the clinical success of cancer immunotherapy Hoos, Axel; Britten, Cedrik M.; Huber, Christoph; O'Donnell-Tormey, Jill NATURE BIOTECHNOLOGY 2011 29 10 867 870
37 Harmonization of immune biomarker assays for clinical studies. van der Burg SH, Kalos M, Gouttefangeas C, Janetzki S, Ottensmeier C, Welters MJ, Romero P, Britten CM, Hoos A. SCIENCE TRANSLATIONAL MEDICINE 2011 3 108
38 The impact of harmonization on ELISPOT assay performance. Janetzki S, Britten CM METHODS MOL BIOL. 2012 792 25 36
39 Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. Moodie Z, Price L, Janetzki S, Britten CM. METHODS MOL BIOL. 2012 792 185 196